Design of novel N-(2,4-dioxo-1,2,3,4-tetrahydro-thieno[3,2-d]pyrimidin-7-yl)-guanidines as thymidine phosphorylase inhibitors, and flexible docking to a homology model

Bioorganic & Medicinal Chemistry Letters
2003.0

Abstract

A novel class of thymidine phosphorylase (TP) inhibitors has been designed based on analogy to the enzyme substrate as well as known inhibitors. Flexible docking studies, using a homology model of human TP, of the designed N-(2,4-dioxo-1,2,3,4-tetrahydro-thieno[3,2-d]pyrimidin-7-yl)-guanidines as well as their synthetic precursors provide insight into the observed experimental trends in binding affinity.

Knowledge Graph

Similar Paper

Design of novel N-(2,4-dioxo-1,2,3,4-tetrahydro-thieno[3,2-d]pyrimidin-7-yl)-guanidines as thymidine phosphorylase inhibitors, and flexible docking to a homology model
Bioorganic & Medicinal Chemistry Letters 2003.0
Structure–activity relationship of 2,4,5-trioxoimidazolidines as inhibitors of thymidine phosphorylase
European Journal of Medicinal Chemistry 2011.0
Design of Novel Inhibitors of Human Thymidine Phosphorylase: Synthesis, Enzyme Inhibition, in Vitro Toxicity, and Impact on Human Glioblastoma Cancer
Journal of Medicinal Chemistry 2019.0
Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis and biological evaluation of novel 1-(aryl-aldehyde-oxime)uracil derivatives as a new class of thymidine phosphorylase inhibitors
European Journal of Medicinal Chemistry 2018.0
Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitors
European Journal of Medicinal Chemistry 2008.0
Design, Synthesis, and X-ray Crystal Structure of Classical and Nonclassical 2-Amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as Dual Thymidylate Synthase and Dihydrofolate Reductase Inhibitors and as Potential Antitumor Agents
Journal of Medicinal Chemistry 2009.0
Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase
Bioorganic & Medicinal Chemistry 2008.0
Design, Synthesis, and Biological Activities of New Thieno[3,2-d]pyrimidines as Selective Type 4 Phosphodiesterase Inhibitors
Journal of Medicinal Chemistry 1998.0